Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
Global API Market Set to Exceed $445 Billion by 2035, Driven by Biologics and Supply Chain Resilience
pharma-industry business earnings

Global API Market Set to Exceed $445 Billion by 2035, Driven by Biologics and Supply Chain Resilience

Newsdesk profile image
by Newsdesk
Updated

AI-Generated Summary

The global Active Pharmaceutical Ingredients (API) market is projected to reach USD 445.7 billion by 2035, growing at a CAGR of 7.15%, driven by increased demand for generics, complex biologics, and outsourced production. APIs are emerging as strategic assets influencing drug pricing, supply chain resilience, and regulatory compliance. This growth is significantly shaped by advancements in biologics, continuous manufacturing, and strategic CDMO partnerships.

In a nutshell

This market expansion underscores the critical need for pharmaceutical executives and investors to strategically diversify API manufacturing, invest in specialty biologics, and leverage CDMO alliances to capitalize on high-growth therapeutic segments and ensure supply chain stability.

Source: PR Newswire UK

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More